Profile
SYRA HCA FMS DVA THC SOLV
Company Name Syra Health Corp. Class A Common Stock HCA Healthcare, Inc. Fresenius Medical Care AG & Co. KGaA DaVita Inc. Tenet Healthcare Corporation Solventum Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Care Facilities Medical - Care Facilities Medical - Care Facilities Medical - Care Facilities Medical - Care Facilities Medical - Care Facilities
Market Cap $4.31M $76.03B $13.29B $12.26B $12.00B $11.38B
Employees 0.08K 220.00K 113.08K 70.00K 78.81K 22.00K
CEO Dr. Deepika Vuppalanchi Ph.D. Mr. Samuel N. Hazen Ms. Helen Giza Mr. Javier J. Rodriguez Dr. Saumya Sutaria M.D. Mr. Bryan C. Hanson
Ratings
SYRA HCA FMS DVA THC SOLV
Quant Rating Score 2 2 3 3 3 2
Quant Rating Sell Sell Neutral Neutral Neutral Sell
Trading
SYRA HCA FMS DVA THC SOLV
Last Close $0.4119 $300.15 $22.64 $149.55 $126.23 $66.06
High 52 $5.01 $415.54 $24.18 $167.96 $168.52 $75.07
Low 52 $0.36 $272.28 $18.12 $103.89 $74.17 $48.02
Price vs. 52 Week High -91.78 % -27.77 % -6.37 % -10.96 % -25.09 % -12 %
Price vs. 52 Week Low 14.42 % 10.24 % 24.94 % 43.95 % 70.19 % 37.57 %
Total Return
SYRA HCA FMS DVA THC SOLV
1 Month Return -9.47 % -8.39 % -0.61 % -8.67 % -11.12 % -8.24 %
3 Month Return 11.32 % -25.68 % 7.1 % -6.01 % -21.99 % -2.32 %
6 Month Return -68.32 % -6.12 % 18.16 % 8.02 % -5.97 % 28.02 %
9 Month Return -68.8 % -8.87 % 20.62 % 10.74 % 22.74 % -1.12 %
YTD Return 0 % 0 % 0 % 0 % 0 % 0 %
1 Year Return -62.38 % 9.02 % 6.59 % 39.91 % 66.03 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SYRA HCA FMS DVA THC SOLV
Dividend Yield Percentage (TTM) - 0.88 % 2.9 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -402.73 % 1.96 % 2.14 % 3.61 % 3.96 % 4.44 %
Dividend Per Share (TTM) - 2.64 % 0.63 % - - -
Payout Ratio (TTM) - 11.55 % 52.99 % - - -
Growth
SYRA HCA FMS DVA THC SOLV
Asset Growth 112.24 % 7.2 % -5.1 % -0.2 % 4.26 % 5.76 %
Gross Profit Growth 32.66 % -81.07 % -7.25 % 12.35 % 6.65 % -0.04 %
Revenue Growth -1.83 % 7.86 % 0.29 % 4.57 % 7.17 % 0.82 %
Revenue 3 Year - 56.56 % 9.17 % 38.68 % 20.35 % 12.58 %
Revenue 5 Year - 75.2 % 145.65 % 100.24 % 12.72 % 12.58 %
Revenue 10 Year - 206.73 % 280.78 % 138.63 % 85.1 % 12.58 %
EBIT Growth -38.18 % 5.81 % 630.04 % 19.69 % 7.59 % -0.06 %
Net Income Growth -38.72 % -7.11 % -25.9 % -9.98 % -38.9 % 0.22 %
Net Income 3 Yeari Growth Per Share -84256.58 % 73.4 % -57.05 % 17.95 % -17.8 % 18.28 %
Net Income 5 Yeari Growth Per Share -84256.58 % 74.24 % -47.39 % 64.65 % 453 % 18.28 %
Net Income 10 Yeari Growth Per Share -84256.58 % 443.67 % 28.57 % 152.44 % 556.01 % 18.28 %
Operating Income Growth -38.18 % 5.81 % 630.04 % 19.69 % 7.59 % -0.06 %
Operating Cash Flow Growth (CFG) -22.95 % 10.67 % 21.31 % 31.6 % 119.21 % 14.06 %
Operating 3 Year CFG - 26.86 % -37.76 % 37.28 % -28.01 % -5.48 %
Operating 5 Year CFG - 75.59 % 166.38 % 118.63 % 127.36 % -5.48 %
Operating 10 Year CFG - 313.58 % 269.44 % 168.49 % 303.09 % -5.48 %
EPS Growth -66.67 % -1.03 % -26.09 % -7.75 % -37.11 % 0.13 %
EPS Diluted Growth -106.9 % -0.99 % -26.09 % -7.48 % -36.91 % 0.13 %
Book Value Per Share 579.01 % 1647.71 % -4.08 % 26.3 % 25.75 % -70.97 %
Share Holder 3 Year Equity Growth Per Share 118079.78 % -485.13 % 10.7 % 0.72 % 5833.33 % -
Share Holder 5 Year Equity Growth Per Share 118079.78 % 54.89 % 120.58 % -46.36 % 1457.52 % -
Share Holder 10 Year Equity Growth Per Share 118079.78 % 65.38 % 321.78 % -44.9 % 113 % -
Dividend Per Share Growth - 7.89 % -16.97 % - - -
Dividend 3 Year Growth Per Share - 436.49 % -6.22 % - - -
Dividend 5 Year Growth Per Share - 70.85 % 111.38 % - - -
Dividend 10 Year Growth Per Share - 6566.99 % 217.34 % - - -
Debt Growth -73.46 % 5.08 % -8.8 % -5.97 % 7.52 % 8640 %
Free Cash Flow Growth -17.29 % 13.57 % 157.17 % 55.13 % 405.61 % 13.8 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023
Profitability
SYRA HCA FMS DVA THC SOLV
Gross Profit Margin TTM 11.82 % 50.04 % 25.14 % 29.88 % 18.8 % 55.47 %
Return on Assets TTM -96.05 % 9.97 % 2.03 % 4.73 % 10.64 % 3.53 %
Return on Equity TTM -131.94 % -330.72 % 4.68 % 110.29 % 101.08 % 15.65 %
Return on Capital Employed TTM -119.79 % 23.57 % 5.8 % 13.26 % 13.59 % 10.56 %
Net Income Per EBT TTM 100 % 67.88 % 56.34 % 58.88 % 61.15 % 67.57 %
EBT Per Ebit TTM 100.02 % 83.17 % 75.76 % 72.83 % 157.88 % 61.63 %
EBIT Per Revenue TTM -54.89 % 15.08 % 8.02 % 15.24 % 15.44 % 15.12 %
Cash Flow To Debt Ratio TTM -1281.46 % 24.74 % 31.22 % 20.56 % 24.88 % 18.66 %
Receivables Turnover TTM 8.09 7.02 5.87 4.81 5.84 7.49
Payables Turnover TTM 32.06 8.21 16.59 18.19 13.46 6.58
Inventory Turnover TTM - 19.58 6.86 68.86 47.84 3.87
Fixed Asset Turnover TTM 2149.74 % 222.8 % 275.75 % 236.41 % 377.74 % 517.45 %
Asset Turnover TTM 174.95 % 117.09 % 59.18 % 72.37 % 71.4 % 56.11 %
Operating Cash Flow Per Share TTM -0.62 41.4 7.75 23.47 33.47 8.73
Free Cash Flow Per Share TTM -0.62 22.9 6.28 16.97 25.01 6.76
Cash Per Share TTM 37.13 % 1124.77 % 581.71 % 1304.06 % 4279.52 % 445.21 %
Operating Cash Flow Sales Ratio TTM -57.8 % 15.27 % 11.82 % 15.51 % 15.27 % 18.29 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.25 % 55.32 % 80.99 % 72.33 % 74.73 % 77.46 %
Cash Flow Coverage Ratios TTM -1281.46 % 24.74 % 31.22 % 20.56 % 24.88 % 18.66 %
Price To Free Cash Flows Ratio TTM -0.96 12.93 6.97 8.63 5.02 9.71
Price To Operating Cash Flows Ratio TTM -0.71 7.25 2.82 6.37 3.77 7.55
Price Cash Flow Ratio TTM -0.71 7.25 2.82 6.37 3.77 7.55
Income Statement (TTM)
SYRA HCA FMS DVA THC SOLV
Revenue $0.01B $64.97B $19.45B $12.14B $20.55B $8.2B
Gross Profit $0B $9.63B $4.93B $3.82B $16.96B $4.69B
Gross Profit Ratio 25.54% 14.82% 25.32% 31.47% 82.53% 57.25%
EBITDA $-0B $12.72B $3.21B $2.32B $3.39B $2.04B
Net Income $-0B $5.24B $0.5B $0.69B $0.61B $1.35B
EPS Diluted -0.6 18.96 1.7 7.42 5.71 7.8
Balance Sheet (MRQ)
SYRA HCA FMS DVA THC SOLV
Long Term Debt $0B $39.07B $10.49B $10.6B $15.89B $8.37B
Total Liabilities $0B $55.15B $19.1B $14.15B $22.8B $10.97B
Total Equity $0B $1.06B $14.83B $2.74B $5.51B $3.41B
Total Investments $0B $1.35B $1.39B $0.61B $1.89B $-0.32B
Total Debt $0B $41.86B $12.05B $11.12B $16.21B $8.3B
Total Assets $0B $56.21B $33.93B $16.89B $28.31B $14.38B
Cash Flow Statement (TTM)
SYRA HCA FMS DVA THC SOLV
Net Income $-0B $5.24B $0.73B $0.69B $0.61B $1.35B
Inventory $0B $0B $-0.01B $-0.03B $-0.14B $0.02B
Dividends Paid $0B $-0.66B $-0.33B $0B $0B $0B
Operating Cash Flow $-0B $9.43B $2.63B $2.06B $2.37B $1.92B
Capital Expenditure $-0B $-4.74B $-0.68B $-0.57B $-0.75B $-0.29B
Related Stocks
Ticker Name Price
ACHC Acadia Healthcare Company, Inc. 40.77
ADUS Addus HomeCare Corporation 124.28
AGL agilon health, inc. 1.925
AIH Aesthetic Medical International Holdings Group Limited 0.3334
AIRS AirSculpt Technologies, Inc. 5.42
ALR AlerisLife Inc. 1.32
AMED Amedisys, Inc. 90.9
AMEH Apollo Medical Holdings, Inc. 40.82
AMN AMN Healthcare Services, Inc. 24.56
AMS American Shared Hospital Services 3.1726
AONC American Oncology Network, Inc. 5.09
ARDT Ardent Health Partners, LLC 16.84
ASTH Astrana Health, Inc. 32.21
ATIP ATI Physical Therapy, Inc. 2.49
AUNA 6.96
AVAH Aveanna Healthcare Holdings Inc. 4.52
BACK IMAC Holdings, Inc. 1.2935
BKD Brookdale Senior Living Inc. 5.065
BKDT Brookdale Senior Living Inc. 7. 70.03
BTMD Haymaker Acquisition Corp. III 6.03
ETFs With Exposure to SYRA
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 289.29
VXF Vanguard Extended Market Index Fund 0 190.36
VTSAX Vanguard Total Stock Market Index Fund 0 141.03
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 144.07
VITSX Vanguard Total Stock Market Index Fund 0 141.05
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 144.08
VEMPX Vanguard Extended Market Index InstlPlus 0 355.55
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 264.58
Unlock